We use our own and third-party cookies to offer our services and collect statistical data. If you continue browsing our site, it is understood that you accept said cookies. More information

Accept
Back

New Royal Decree Analyzed in 'Conference on Clinical Trials.'

20-09-2017
New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'
New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'New Royal Decree Analyzed in 'Conference on Clinical Trials.'
The collaboration between the European University and BioClever is still paying off, on this occasion, by holding the ‘Conference on Clinical Trials’ with the participation of many highly regarded speakers.

The first participant was Dr. Ángel Navarro, president and founder partner of Azierta, who presented the main changes in the New Royal Decree (RD) 1090/2015. Furthermore, he outlined a national picture of clinical research, times and efforts, both financial and human, that are necessary to put a new medication within society's reach.

Next,  Dr. Antonio Portolés, director of the Foundation for Biomedical Research of the Hospital Clínico San Carlos, focused his presentation on non-commercial research promoted from public hospitals or scientific associations. In order to develop this type of studies, he mentioned the vital importance of  obtaining grants from governments and supranational authorities.

The last presentation was given by Ana Isabel Terleira, Vice-president of the Ethical Committee of the Hospital de Alcorcón and clinical pharmacologist at the Hospital Clínico San Carlos, who focused on determining the implications of the New Royal Decree for CRECs (Clinical Research Ethics Committees) and how this affects the process in hospitals and several sponsors.

The conference ended with a discussion forum between speakers and attendees, moderated by Eva Martín, founding partner of Kinrel, in which the main concerns were related with the difficulty to unify processes. The importance of clinical research for the advance of medicine and improving patients' quality of life was also discussed. Among the attendees, there were several investigators, research personnel from scientific associations, persons responsible for scientific research foundations of public and private hospitals of the community of Madrid, and many representatives from medical and clinical surgery departments from several renown pharmaceutical and biotechnological laboratories.

Related news